Aftificial Inteligence in Assisted Reproductive Techniques to Assess Oocyte Quality and Embryo Ploidy
Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Aug 1, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how artificial intelligence (AI) can help improve the chances of successful pregnancies in people facing infertility. The study focuses on assessing the quality of eggs (oocytes) and embryos using advanced imaging techniques, which could lead to better choices in fertility treatments. By analyzing various factors, including the condition of the eggs and sperm, the trial aims to predict the likelihood of pregnancy more accurately and reduce the costs associated with fertility treatments.
To participate in this trial, individuals must be undergoing specific fertility procedures like intracytoplasmic sperm injection or preimplantation genetic testing, and they need to provide signed consent. Unfortunately, those with certain gynecological or genetic diseases are not eligible. Participants can expect to be part of a process that investigates new ways to enhance fertility treatment outcomes, potentially allowing for more efficient and cost-effective care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Intracytoplasmatic Sperm Injection
- • Preimplantation genetic testing
- • Time lapse embryo record
- • Singned informed consent
- Exclusion Criteria:
- • Gynecological diseases
- • Genetical diseases of parents
About Charles University, Czech Republic
Charles University, located in the Czech Republic, is a prestigious institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct innovative research that aims to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and rigorous scientific methodologies, Charles University collaborates with various stakeholders to explore new therapies and enhance healthcare practices, fostering a culture of excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Prague, , Czechia
Prague, , Czechia
Prague, , Czechia
Vestec, , Czechia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported